Cardina Health's trading volume on March 2nd was $402 million, ranking 325th among U.S. stocks on that day.

K-LinePoet · 2026-03-11T01:39:33+00:00

Cardina Health (CAH) had a trading volume of $402 million on March 2, 2026, down 14.94% from yesterday, with the stock price increasing by 0.28% on the same day. The company's mid-year report for fiscal year 2026 shows revenue increased by 20.55% year-over-year, and net profit grew by 13.08%.

K-LinePoet

2026-03-11 01:39:33

Abstract generation in progress

On March 2, 2026, Cardina Health (CAH), a healthcare and nursing product distributor, had a trading volume of $402 million, ranking 325th among U.S. stocks that day. Its trading volume decreased by 14.94% compared to the previous day, with a total of 1.7491 million shares traded.

On March 2, 2026, Cardina Health (CAH) increased by 0.28%, closing at $229.88. The stock has risen 2.25% over the past five trading days, 0.28% for the entire month of March, 11.86% since the beginning of the year, and 77.54% over the past 52 weeks.

If the company has been listed for less than 52 weeks, the 52-week change is calculated from the listing date to the present (this also applies to listings of less than 1 month or fewer than 5 trading days).

Cardina Health (CAH)	Trading Volume / USD	Change from Previous Day	Shares Traded
March 2, 2026	$402 million	-14.94%	1.7491 million
February 27, 2026	$473 million	78.24%	2.0669 million
February 26, 2026	$265 million	33.55%	1.1671 million
February 25, 2026	$199 million	-38.26%	0.8786 million
February 24, 2026	$322 million	5.58%	1.4349 million

Cardina Health released its fiscal year 2026 interim report on February 5, 2026. From July 1, 2025, to December 31, 2025, revenue was $129.636 billion, a 20.55% increase year-over-year, with a net profit of $925 million, up 13.08% year-over-year.

Cardina Health Group, founded in 1979 in Ohio, is a globally integrated healthcare services and products company. It provides customized solutions for hospitals, healthcare systems, pharmacies, outpatient surgical centers, clinical laboratories, physician offices, and home patients. The company offers pharmaceuticals and medical products, as well as cost-effective solutions to improve supply chain efficiency. It connects patients, providers, payers, pharmacists, and manufacturers to achieve coordinated care and better patient management. The company manages its operations and reports financial performance, divided into two segments: Pharmaceuticals and Healthcare.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.